dog |
LDLo |
subcutaneous |
200mg/kg (200mg/kg) |
? |
"Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1352, 1935. |
guinea pig |
LDLo |
intraarterial |
500mg/kg (500mg/kg) |
? |
Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 131, Pg. 171, 1928. |
guinea pig |
LDLo |
intravenous |
500mg/kg (500mg/kg) |
? |
Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 131, Pg. 171, 1928. |
guinea pig |
LDLo |
subcutaneous |
100mg/kg (100mg/kg) |
? |
"Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1352, 1935. |
mammal (species unspecified) |
LDLo |
oral |
300mg/kg (300mg/kg) |
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)
LUNGS, THORAX, OR RESPIRATION: DYSPNEA |
Journal of Industrial Hygiene. Vol. 13, Pg. 87, 1931. |
mouse |
LD50 |
intraperitoneal |
500mg/kg (500mg/kg) |
? |
National Technical Information Service. Vol. AD277-689, |
mouse |
LD50 |
oral |
571mg/kg (571mg/kg) |
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)
BEHAVIORAL: IRRITABILITY |
Acute Toxicity Data. Journal of the American College of Toxicology, Part B. Vol. 12, Pg. 598, 1993. |
rabbit |
LD |
skin |
> 2gm/kg (2000mg/kg) |
? |
Acute Toxicity Data. Journal of the American College of Toxicology, Part B. Vol. 12, Pg. 596, 1993. |
rat |
LD50 |
oral |
475mg/kg (475mg/kg) |
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
BEHAVIORAL: EXCITEMENT
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" |
National Technical Information Service. Vol. AD-A165-747, |
rat |
LDLo |
subcutaneous |
404mg/kg (404mg/kg) |
? |
Journal of Pharmacology and Experimental Therapeutics. Vol. 28, Pg. 251, 1926. |